Switch to:
More From Other Websites
Alexion (ALXN) Files for Soliris' Label Expansion in Japan Mar 23 2017
4:06 pm Alexion Pharma submits an application to Japan's Ministry of Labour and Welfare to extend... Mar 22 2017
Alexion Submits Application in Japan for Soliris® (Eculizumab) as a Potential Treatment for... Mar 22 2017
Alexion Submits Application in Japan for Soliris® (Eculizumab) as a Potential Treatment for... Mar 22 2017
Alexion (ALXN) Licenses Artubus Technology for Rare Diseases Mar 17 2017
Arbutus Licenses LNP Delivery Technology to Alexion for Use in Single Messenger RNA Product... Mar 16 2017
Pharmaceutical company to lay off more than 200 employees Mar 15 2017
Pharmaceutical company to lay off more than 200 employees Mar 15 2017
Alexion Trims Workforce, Scraps R&D Programs Mar 14 2017
Alexion Pharmaceuticals Cuts 7% of Workforce Mar 14 2017
England Says No to Drugs That Cost More Than Your Car (or Home) Mar 14 2017
Alexion to cut 7 pct of workforce Mar 13 2017
Alexion's sBLA for Soliris Receives FDA Acknowledgement Mar 10 2017
FDA Accepts sBLA Filing of Soliris® (Eculizumab) as a Potential Treatment for Patients with... Mar 08 2017
ALEXION PHARMACEUTICALS INC Files SEC form 8-K, Change in Directors or Principal Officers, Financial... Mar 02 2017
Leonard Bell, M.D., Alexion’s Founder, Announces Plans to Retire as Chairman and Board Member Mar 02 2017
Coverage initiated on Alexion Pharma by Instinet Mar 02 2017
Alexion Expects This to Be Big Medicine in 2017 Mar 01 2017
Will Alexion’s Research Make Gains in the Inhibitor Space? Feb 28 2017
What Alexion Expects from Its Metabolic Disease Drugs in 2017 Feb 28 2017


Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK